TEVA-NALOXONE NASAL SPRAY
TEVA-NALOXONE NASAL SPRAY
Approved
DIN Number
02511568
Drug Class
Human
Market Date
Jan 8, 2024
Company
HC
teva canada limited
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02511568
AIG Number0108981005
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
V03AB15 NALOXONE
Product Specifications
Dosage FormSpray, Metered Dose
Route of AdministrationNasal
AHFS Classification28:10.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
NALOXONE HYDROCHLORIDEActive
Strength: 4 MG / 0.1 ML
Monograph: NALOXONE HYDROCHLORIDE